Clinical Trials List
2017-02-28 - 2020-06-09
Phase III
Terminated5
-
Trial Applicant
Syneos Health
-
Sponsor
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- Jih-Hsiang Lee Division of Hematology & Oncology
- 廖唯昱 Division of General Internal Medicine
- 陳冠宇 Division of General Internal Medicine
- James Chih-Hsin Yang Division of Hematology & Oncology
- CHAO-CHI HO CHAO-CHI HO Division of General Internal Medicine
- 許嘉林 Division of General Internal Medicine
- 廖斌志 Division of Hematology & Oncology
- JIN-YUAN SHIH Division of General Internal Medicine
- 徐偉勛 Division of Hematology & Oncology
- Chong-Jen Yu Division of General Internal Medicine
- 蔡子修 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 趙東瀛 Division of Thoracic Medicine
- 蘇茂昌 Division of Thoracic Medicine
- CHIN-CHOU WANG Division of Thoracic Medicine
- 張晃智 Division of Thoracic Medicine
- 鍾聿修 Division of Thoracic Medicine
- 黃國棟 Division of Thoracic Medicine
- Chia-Cheng Tseng Division of Thoracic Medicine
- 王逸熙 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 蕭慈慧 Division of Thoracic Medicine
- Chi-Lu Chiang Division of Hematology & Oncology
- Chao-Hua Chiu Division of Hematology & Oncology
- 趙恒勝 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- KUO-HSUAN HSU Division of Thoracic Medicine
- JENG-SEN TSENG Division of Thoracic Medicine
- 陳焜結 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
22 participants
-
Global
280 participants
